Table 1 Rectal cancer patients’ characteristics according to sex
Men, n (%) | Women, n (%) | |
|---|---|---|
Age in years, mean [range] | 70 [46–88] | 69 [29–91] |
Stage | ||
I | 16 (18) | 13 (16) |
II | 19 (19) | 16 (23) |
III | 47 (46) | 35 (49) |
IV | 20 (20) | 7 (10) |
Differentiation grade | ||
Good | 9 (9) | 6 (8) |
Moderate | 66 (65) | 43 (61) |
Poor | 27 (26) | 22 (31) |
Tumour location | ||
Low (≤ 5cm) | 39 (38) | 22 (31) |
Middle (> 5–10 cm) | 34 (33) | 28 (39) |
Upper (> 10–15 cm) | 29 (29) | 21 (30) |
RTa | ||
Short-course RTb | 51 (50) | 32 (45) |
Long-course RTc | 3 (3) | 0 |
Long-course CRTd | 11 (11) | 15 (21) |
Palliative RT | 1 (1) | 2 (3) |
No RT | 36 (35) | 22 (31) |
Surgerya | ||
Yes | 94 (92) | 68 (96) |
No | 8 (8) | 3 (4) |
Neoadjuvant chemotherapy | ||
Oxaliplatin-based | 17 (17) | 11 (16) |
Non-oxaliplatin-based | 2 (2) | 1 (1) |
No | 83 (81) | 59 (83) |
Adjuvant chemotherapy | ||
Oxaliplatin-based | 16 (16) | 8 (11) |
Non-oxaliplatin-based | 12 (12) | 7 (10) |
No | 74 (72) | 56 (79) |
History of coronary artery diseasee | ||
Yes | 10 (10) | 6 (8) |
No | 92 (90) | 65 (92) |
History of diabetese | ||
Yes | 15 (15) | 9 (13) |
No | 87 (85) | 62 (87) |
History of hypertensione | ||
Yes | 40 (39) | 27 (38) |
No | 62 (61) | 44 (62) |
Use of beta-blockerse | ||
Yes | 39 (38) | 27 (38) |
No | 63 (62) | 44 (62) |
Body mass index | ||
< 25 | 42 (41) | 33 (47) |
≥ 25 | 54 (53) | 35 (49) |
Missing data | 6 (6) | 3 (4) |
SMI cm2/m2, mean (± SD) | 45.8 (± 6.6) | 36.2 (± 6.2) |
VAT cm2, mean (± SD) | 166.7 (± 98.3) | 83.9 (± 58.9) |